Curtana Pharmaceuticals is a privately-held, preclinical-stage biopharmaceutical company developing first-in-class, small molecule therapeutics that are highly specific for cancer stem cells in the central nervous system (CNS) for the treatment of glioblastoma (GBM) and other brain cancers.

Biotechnology

Pharmaceutical

Curtana Pharmaceuticals

Gregory Stein

Fabio Tucci

David M. Weiner

Daniel Pertschuk

Mark Sorenson

Lawrence J. Trost

Michelle Rose

The Scientific Advisors at Curtana Pharmaceuticals provide expert guidance on research and development strategies, ensuring that the company’s small molecule therapeutics specifically target cancer stem cells in the CNS. They evaluate preclinical data, advise on clinical trial designs, and stay abreast of the latest scientific advancements to optimize the treatment of glioblastoma and other brain cancers.

Scientific Advisors

Leadership Team

Product Development and Regulatory Team

Scientific Advisors

About

Team members

Other teams at Curtana Pharmaceuticals

Leadership Team

Product Development and Regulatory Team